DUX4L9 and facioscapulohumeral muscular dystrophy: This further strengthens our hypothesis that the DUX4:DUX4c ratio contributes to altered β-CATENIN signalling in FSHD muscles, and the likelihood that these 17 genes could be a biomarker for severe FSHD.